Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.

The IgA antibody response to respiratory syncytial virus (RSV) was determined in nasopharyngeal secretions (NPS) of 22 infants and children infected with RSV group A strains, employing an ELISA. The antibody activity observed during the convalescent phase against whole virus, fusion glycoprotein (F) and large glycoprotein (G) was examined in young infants (under 6 months) and compared with that of older individuals (6 to 16 months). Both groups showed similar degrees of IgA antibody activity to whole virus in NPS; however, older individuals showed a significantly higher activity of IgA F antibody than that of IgA G antibody in the NPS. On the other hand, in the NPS of young infants, IgA F antibody was somewhat suppressed and IgA G antibody activity predominated over that of IgA F. Pre-existing (maternal) serum IgG anti-RSV F antibody activity was higher than that of antibody to G. A significant reverse correlation was observed between the activity of pre-existing serum IgG F antibody and NPS IgA F antibody in the convalescent phase after primary infection with RSV. These observations suggest that maternally derived RSV IgG antibody, which contains abundant anti-F activity, may suppress the development of IgA F antibody response at infection sites in the respiratory tract in young infants during primary RSV infection. These changes may be related to the severity of acute infection and longer convalescence often observed in young infants during RSV infection.

[1]  E. Walsh,et al.  Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children. , 1993, The Journal of infectious diseases.

[2]  P. Ogra,et al.  Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection , 1989, Journal of clinical microbiology.

[3]  H. Tsutsumi,et al.  Antigenic variation of human RSV strains isolated in Japan , 1989, Journal of medical virology.

[4]  P. Collins,et al.  The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. , 1988, The Journal of general virology.

[5]  J. Sinnott,et al.  Respiratory Syncytial Virus , 1988, Infection Control & Hospital Epidemiology.

[6]  G. Prince,et al.  Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children , 1987, Antimicrobial Agents and Chemotherapy.

[7]  P. Collins,et al.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Moss,et al.  Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Walsh,et al.  Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection , 1986, Journal of clinical microbiology.

[10]  J. Schlesinger,et al.  Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies. , 1986, The Journal of general virology.

[11]  J. Schlesinger,et al.  Purification and characterization of the respiratory syncytial virus fusion protein. , 1985, The Journal of general virology.

[12]  D. Wong,et al.  Secretory antibody response to respiratory syncytial virus infection. , 1981, American journal of diseases of children.

[13]  K. Mcintosh,et al.  The immunologic response to infection with respiratory syncytial virus in infants. , 1978, The Journal of infectious diseases.

[14]  R. Chanock,et al.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. , 1973, American journal of epidemiology.

[15]  R. Chanock,et al.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. , 1973, American journal of epidemiology.